In an article published in the Journal of the National Cancer Institute, they reported that based on results from 250 patients as well as records from 2,000 patient outcomes recorded in the National Cancer Database, neoadjuvant chemotherapy was associated with worse survival outcomes after surgery than the outcomes of patients whose surgeries were scheduled immediately, without waiting for a course of chemotherapy to be completed.
For more than 35 years, the Philadelphia-based law firm of NASS CANCELLIERE has represented 4,000 workers who have contracted MESOTHELIOMA and other forms of asbestos-related illness. Our attorneys have tried over 1,000 cases throughout Pennsylvania and New Jersey. We have collected over $500 million for our clients. Learn more at nasscancelliere.com or call 215-546-8200 to speak with an attorney.